Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.05.2015 | Clinical study

Long-term PPI therapy safe

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Long-term treatment with the proton pump inhibitors (PPIs) omeprazole and esomeprazole is not associated with any safety concerns, according to an analysis of tolerability data from the SOPRAN and LOTUS studies. …
Literatur
Zurück zum Zitat Attwood SE, et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Alimentary Pharmacology and Therapeutics 41: 1162-1174, No. 11, Jun 2015. Available from: URL: http://doi.org/10.1111/apt.13194 CrossRefPubMed Attwood SE, et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Alimentary Pharmacology and Therapeutics 41: 1162-1174, No. 11, Jun 2015. Available from: URL: http://​doi.​org/​10.​1111/​apt.​13194 CrossRefPubMed
Metadaten
Titel
Long-term PPI therapy safe
Publikationsdatum
01.05.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-1772-6

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Minoxidil

Case report

Adalimumab